Citigroup Inc Greenwich Life Sciences, Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 4,879 shares of GLSI stock, worth $59,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,879
Previous 4,308
13.25%
Holding current value
$59,035
Previous $61,000
11.48%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding GLSI
# of Institutions
39Shares Held
1.11MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.74 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA275KShares$3.33 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA134KShares$1.62 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL87.4KShares$1.06 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.05 Million0.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $155M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...